OMER FY 2009 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$813M

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+23.4% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$21M-1437.5% margin

Net Income

-$21M-1460.5% margin

EPS (Diluted)

$-2.92

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$62M

Total Liabilities

$19M

Stockholders' Equity

$43M

Cash & Equivalents

$820,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$1M	+23.4%
Gross Profit	$1M	$1M	+23.4%
Operating Income	-$21M	-$25M	+15.4%
Net Income	-$21M	-$24M	+11.5%